Total Product Lifecycle Solutions from NSF Health Sciences Medical Devices
|
|
- Harry Holland
- 8 years ago
- Views:
Transcription
1 Total Product Lifecycle Solutions from NSF Health Sciences Medical Devices Experts in medical device quality systems, compliance, regulatory affairs, auditing and training
2 The Right People. The Right Solution. The First Time. Medical device companies operate in a complex global regulatory environment with continually changing standards. NSF Health Sciences has a team of experts in the regulatory, scientific, analytical testing and compliance fields that understands the industry and regulatory requirements to bring medical devices to market and sustain them throughout their lifecycle. NSF Health Sciences Medical Devicea services can assist companies in navigating U.S. and international regulatory hurdles from product inception through product marketing.
3 Comprehensive Services NSF Health Sciences Medical Devices provides these services: > Quality systems implementation, remediation, compliance and assessment > Inspection readiness and mock audits > Regulatory strategy / clinical support and submissions > Corporate compliance program design, implementation and sustainment > Training and education NSF Health Sciences Medical Devices maintains a commitment to outstanding service and quality, and focuses on achieving the client s business objectives through the use of sound science and expert experience. Our total product lifecycle approach allows us to provide our clients with the best solutions for their regulatory needs. PROTOTYPE CONCEPT OBSOLESCENCE PRECLINICAL COMMERCIAL USE CLINICAL MARKETING MANUFACTURING
4 The Right People. The Right Solution. The First Time. NSF Health Sciences Medical Devices provides international regulatory consulting services including FDA and EU expertise to support the development, marketing, and stewardship of medical devices, including in vitro diagnostics and combination products. Our core expertise is the design and implementation of successful efforts to resolve, or avoid, challenges posed in the development of new, innovative products. We work with a network of subject-matter experts, across all therapeutic areas, to provide our clients with appropriate expertise in any field. In all of our assignments, we work to balance complying with the regulatory requirements with our clients business needs. For more information about NSF Health Sciences Medical Devices and our services, please contact us at medicaldevices@nsf.org or call
5 Clinical-Regulatory Strategy and Submissions NSF Health Sciences Medical Devices provides international regulatory consulting services including FDA and EU expertise to support the development, marketing and stewardship of medical devices, including in vitro diagnostics and combination products. Our core expertise is the design and implementation of successful efforts to resolve, or avoid, challenges posed in the development of new, innovative products. In addition to our consultants, who bring FDA and industry expertise to your projects, we work with a network of subject-matter experts, across all therapeutic areas, to provide our clients with the utmost quality and expertise in any field. In all of our assignments, we seek to balance complying with the regulatory requirements with our clients business needs. NSF Health Sciences Medical Devices regulatory team provides a range of specific services to meet all of your regulatory needs across the product development and marketing continuum. > Strategic consultation Regulatory strategy: product classification, submission type, predicate device recommendations, applicable standards and guidance documents Emerging regulatory issues: mobile medical applications, combination products Due diligence >>>
6 Clinical-Regulatory Strategy and Submissions > Regulatory submissions and support in therapeutic areas Pre-market submissions: IDE, 510(k), de novo, PMA, amendments, technical file/design dossier for European CE marking Post-marketing submissions: PMA supplements, 510(k)s for changes, annual reports and post-market studies Responses to submission deficiency letters and additional information requests > Product development documentation development and evaluation Preclinical testing: safety and performance testing plans, protocols and reports Risk analysis: dfmea, pfmea, fault tree analysis and safety assurance cases Design and development plans and traceability matrices > FDA and European agency interactions > Training Informational, pre-submission and submission issue meetings Competent authority scientific briefings Advisory panel preparation and support* Dispute resolution and administrative appeal Clinical study design and evaluation and SR/NSR determinations Patient population identification and endpoint selection Protocol development support Statistical analysis plans Report, manuscript and publication development Human factors evaluations and labeling comprehensions studies FDA and EU classification of medical devices CE marking and U.S. marketing authorization pathways > Global regulatory filings and global strategies NSF Health Sciences Medical Devices 2001 Pennsylvania Avenue NW, Suite 950, Washington, DC USA Tel: LMD
7 Corporate Compliance and Integrity Programs NSF Health Sciences Medical Devices is expanding its service offerings to provide consulting, auditing and training to support the effectiveness of compliance programs as established by the Health and Human Services Office of the Inspector General (OIG). The NSF Health Sciences Medical Devices Corporate Compliance and Integrity Programs group brings you a team of former industry compliance executive and management professionals with over 25 years of experience in the pharmaceutical and medical device industries. The NSF team assists clients in the development, implementation and continuous improvement efforts of ethics and compliance programs. Using tested strategies to mitigate risk through collaborative efforts, we can support the business and compliance needs of your entire organization. The broad range of services includes: > Strategic consultation Compliance program design, implementation and sustainment (including gap analysis of existing compliance programs) > Federal health care programs fraud and abuse prevention training > Corporate Integrity Agreement compliance support > Internal review organization services > Board of directors compliance expert services >>>
8 Corporate Compliance and Integrity Programs Services continued: > Clinical, commercial and post-market activities auditing and monitoring > Internal and external investigation support > Open payments reporting > Anti-bribery and expert controls counseling > Auditing and monitoring of sales force For more information, contact or visit NSF Health Sciences Medical Devices 2001 Pennsylvania Avenue NW, Suite 950, Washington, DC USA Tel: LMD
9 Quality Systems Compliance, Remediation and Auditing NSF Health Sciences Medical Devices services in compliance and quality systems provide business-forward compliance solutions to our clients. Our staff of former FDA and EU officials as well as industry experts allows us to combine global regulatory knowledge with industry best practices to help our clients achieve a compliant quality system that is right for their business. We utilize a systems approach to ensure deficiencies are identified and addressed at their root cause, appropriate procedures and metrics are developed, and that linkages between the quality subsystems support a continuous improvement process for sustainable compliance. We provide these services in core compliance and quality systems: > Third-party GxP system-based gap analyses Targeted deep dive assessments Mock FDA inspection and FDA-readiness support (QSIT approach) Due diligence assessments Mock European regulatory agency audits > Quality systems implementation and development Metric development, compliance scorecards and dashboards Coaching and mentoring Project management Reengineering and process mapping SOP writing QS software evaluation, SDLC requirements and postimplementation assessments >>>
10 Quality Systems Compliance, Remediation and Auditing > Remediation and compliance support in response to enforcement action(s) > Training Corrective action plans development and implementation FDA 483 and warning letter responses Injunctions (consent decree) Recalls and import detentions AIP resolution Corporate Integrity Agreements (CIA) 21 CFR 820 Quality System Regulation 21 CFR 803 Medical Device Reporting 21 CFR 806 Corrections and Removals Audit readiness Quality system subsystem-specific training sessions including; CAPA, management review, design control and risk management For more information, contact or visit NSF Health Sciences Medical Devices 2001 Pennsylvania Avenue NW, Suite 950, Washington, DC USA Tel: LMD
11 International Services: European Expertise NSF Health Sciences Medical Devices has European based experts that support our clients in their CE Marking and European Medical Device Training needs. Our experts have extensive professional experience in both European Regulatory agencies (Competent authority and Notified body) and EU regulated industry. Our Services Include: Regulatory and Clinical Services > European regulatory body interactions > CE Marking expertise including classification decisions and competent authority briefings > European Clinical Trial Design, Investigation and Clinical Evaluations > Technical file/ design dossier development and review including Regulatory Science Expert reports Quality Systems and compliance > ISO13485 Quality System Implementation > Notified body audit preparation > Supply Chain approval as part of a CE marked device > CE Marking and ISO13485 audits > EU safeguarding and Notified body CE marking withdrawal remediation Training and Medical Device QARA professional qualifications > Company-Wide Quality and Regulatory awareness modules > Professional Certificates and Post-Graduate Qualifications in Quality Assurance and Regulatory affairs > Lead and Internal Auditing training program > Industry and Regulator focused Study days covering a range of Regulatory, Quality and Medical Device professional topics >>>
12 Our People James Pink Vice President, Europe Mr. Pink has 16 years experience in the medical devices industry including 10 years as a HealthCare Technology Expert and Lead Auditor for a leading European Notified body. His industry experience includes managing development and quality assurance programs for Orthopedic, Cardiovascular, Wound and Combination products. He has a team of experts based in Europe who have over 20 years individual experience in both Competent Authority and Notified body leadership. James has coordinated and presented to EU competent authorities and expert working groups relating to classification decisions, clinical study design, scientific and technical briefings as well as EU remediation strategies. Yvonne Middlefell, BA Hons RAC FRAPS Executive Director Ms. Middlefell leads our European Regulatory Strategy and Clinical services having extensive experience in Global Medical Device Regulatory Affairs. She has worked for a number of key multinational corporations. These include Amersham Nycomed, Eastman Kodak, Bausch and Lomb and a 25 year tenure at Johnson and Johnson. Her RA experience includes developing Global Regulatory strategies for IVD s, Medical Devices, OTC products, Biologics and Pharmaceuticals. Ms. Middlefell has written and filed multiple CE Technical files and US 510(k) s for a range of products that include immunoassays, clinical chemistry analyzers, infectious disease products, contact lenses and solutions. In addition she has successfully managed a full PMA for an IVD US product submission. She was her company s primary interface with regulatory agencies and industry bodies such as AdvaMed (USA) and EDMA (EU). NSF Health Sciences Medical Devices 2001 Pennsylvania Avenue NW, Suite 950, Washington, DC USA Tel: medicaldevices@nsf.org LMD
13 Our People Experts at NSF Health Sciences Medical Devices Elaine Messa, RAC, FRAPS President, Health Sciences Medical Devices Elaine Messa has over 30 years of experience in FDA regulation of medical devices, focused on the development and implementation of compliance quality systems for medical devices in the United States and abroad. Her most recent position at the U.S. FDA was Director of the Los Angeles District. Ms. Messa has significant experience in auditing, agency communication, development of quality systems, and design and implementation of corrective action plans to address complex compliance situations including consent decrees, Corporate Integrity Agreements, warning letters and 483s. Timothy Ulatowski Vice President, Regulatory & Compliance Timothy Ulatowski has over 36 years of public health experience, including more than 20 years in multiple leadership positions at the U.S. FDA s Center for Devices and Radiological Health (CDRH). He most recently served as Director of the Office of Compliance at CDRH, where he managed and supervised four divisions responsible for ensuring compliance with medical device regulations. Mr. Ulatowski has proven expertise in advising industry on regulatory issues, assessing compliance and enforcement actions, evaluating pre-market documents and resolving complex technical and scientific problems. >>>
14 Our People Mary C. Getz, Ph.D. Vice President, Quality Systems & Compliance Dr. Getz has over 25 years of industry experience, including extensive expertise in developing quality, compliance and regulatory affairs strategies and solutions. She has helped domestic and international manufacturers to develop and implement comprehensive compliance action plans. The results were effective quality systems which lead to successful FDA and notified body inspections as well as NDA and PMA product approvals. Dr. Getz has handson experience with IVDs, 510(k) and PMA medical devices, as well as OTC and NDA pharmaceuticals. She has held vice president-level roles in quality and regulatory affairs at numerous multinational companies within the healthcare sector. James Pink Vice President, Europe Mr. Pink has 16 years experience in the medical devices industry including 10 years as a HealthCare Technology Expert and Lead Auditor for a leading European Notified body. His industry experience includes managing development and quality assurance programs for Orthopedic, Cardiovascular, Wound and Combination products. He has a team of experts based in Europe who have over 20 years individual experience in both Competent Authority and Notified body leadership. James has coordinated and presented to EU competent authorities and expert working groups relating to classification decisions, clinical study design, scientific and technical briefings as well as EU remediation strategies. For more information, contact medicaldevices@nsf.org or visit NSF Health Sciences Medical Devices 2001 Pennsylvania Avenue NW, Suite 950, Washington, DC USA Tel: medicaldevices@nsf.org LMD
15 Our People Experts in Corporate Compliance and Integrity at NSF Health Sciences Francisco Rivas, Esq. Vice President, Corporate Compliance & Integrity Programs Mr. Rivas has over 25 years of experience in senior roles in the pharmaceutical and medical device industry, where he has provided counseling and guidance on compliance and risk management of commercial, quality and clinical issues. He has negotiated with or presented to U.S. FDA advisory committees as well as the FDA and Office of Inspector General (OIG) on issues pertaining to his clients. Most recently, Mr. Rivas was Vice President and Chief Compliance Officer for a medical device company under a Corporate Integrity Agreement (CIA) with the OIG. Katie Norris Director, Compliance & Integrity Programs Ms. Norris has over 10 years of experience in corporate governance and compliance in the pharmaceutical, medical device, OTC consumer products and cosmetics industries. She has performed substantial internal investigations and supported extensive federal investigations with multiple agencies including the U.S. Department of Justice, Health and Human Services Office of Inspector General and the Securities and Exchange Commission. Ms. Norris assists clients with internal and external investigations; remediation of cross functional compliance concerns (including implementation and compliance with CIAs & DPAs); and the operational aspects of compliance program development, management and oversight, including aggregate spend initiatives. NSF Health Sciences Medical Devices Tel: medicaldevices@nsf.org LMD
RAPS ONLINE UNIVERSITY
RAPS ONLINE UNIVERSITY Practical education and training for business success. For regulatory professionals, there is only one name to know and trust for online education and training RAPS Online University.
More informationIVD Regulation Overview. Requirements to Assure Quality & Effectiveness
IVD Regulation Overview Requirements to Assure Quality & Effectiveness CLIAC Jan. 2002 Statutory and Regulatory Requirements Statute: Food, Drug, and Cosmetic Act Food and Drugs Act of 1906 Food and Drug
More informationPreparing for Unannounced Inspections from Notified Bodies
Preparing for Unannounced Inspections from Notified Bodies Europe has introduced further measures for unannounced audits of manufacturers by notified bodies. With this in mind, James Pink, VP Europe-Health
More informationORACLE CONSULTING GROUP
ORACLE CONSULTING GROUP An Official United States Agent Firm for Foreign Establishments CONSULTING MEMORANDUM: DEALING WITH A MEDICAL DEVICE IN THE U.S. 5398 Golder Ranch Rd., Ste. 1 Tucson, Arizona 85739
More informationRegulatory Affairs Professional Development Framework AN OVERVIEW
Regulatory Affairs Professional Development Framework AN OVERVIEW TABLE OF CONTENTS Abstract...2 Introduction...2 Approach...3 Professional Development Framework...3 Professional Levels...3 Domains...4
More informationWHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE
WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 globalsales@maetrics.com
More informationPlamena Entcheva-Dimitrov, PhD, RAC On-line Course. www.preferredregulatoryconsulting.com 1
Plamena Entcheva-Dimitrov, PhD, RAC On-line Course 1 The Preferred Regulatory Consulting content in this presentation is copyright protected under United States law and applicable international copyright
More informationMedical Product Software Development and FDA Regulations Software Development Practices and FDA Compliance
Medical Product Development and FDA Regulations IEEE Orange County Computer Society March 27, 2006 Carl R. Wyrwa Medical Product Development and FDA Regulations Introduction Regulated FDA Overview Medical
More informationCombination Products Regulation in the United States
Combination Products Regulation in the United States Presenter: Scott Sardeson RAC US/EU 3M Health Care St. Paul, MN USA 1 Presentation Outline Combination products Definitions and Regulations Jurisdiction
More informationPremarket Approval Applications (PMAs), Product Development Protocols (PDPs), and Humanitarian Device Exemptions
FDLI s Introduction to Medical Device Law and Regulation: Understanding How FDA Regulates the Medical Device Industry October 28-29, 2002 The Westin Grand Hotel Washington, D.C. Premarket Approval Applications
More informationRegulatory Submission: Applying GLP in Surgical Efficacy Studies
Regulatory Submission: Applying GLP in Surgical Efficacy Studies Curtis Schondelmeyer, DVM Director Preclinical Veterinary Services and Efficacy and Surgical Research Services Welcome to Toxikon 2 CONFIDENTIAL
More informationGuidance for Industry and Food and Drug Administration Staff
Requests for Feedback on Medical Device Submissions: The Pre-Submission Program and Meetings with Food and Drug Administration Staff Guidance for Industry and Food and Drug Administration Staff Document
More informationHow to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters
environmental failure analysis & prevention health technology development How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters Kevin L. Ong, Ph.D., P.E. Managing
More informationJanuary 12, 2016. Dear Amy Yang:
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 January 12, 2016 Amy
More informationMobile Medical Application Development: FDA Regulation
Mobile Medical Application Development: FDA Regulation Mobile Medical Applications: Current Environment Currently over 100,000 mobile health related applications are available for download; there is an
More informationRAC (US) Examination Study Checklist
RAC (US) Examination Study Checklist Instructions: Use this checklist to track your progress when preparing for the RAC (US) certification examination. When you begin your studying, each task statement
More informationGE Healthcare MAR 1 2013
K130155 Pagel1 of 2 GE Healthcare MAR 1 2013 510(k) Summary In accordance with 21 CFR 807.92 the following summary of information is provided: Submitter: Primary Contact Person: Secondary Contact Person:
More informationOverview of Medical Device Design Controls in the US. By Nandini Murthy, MS, RAC
Overview of Medical Device Controls in the US By Nandini Murthy, MS, RAC 18 controls are a regulatory requirement for medical devices. In the US, compliance with the design controls section of 21 Code
More informationThe Medical Device Industry in Korea: Strategies for Market Entry
The Industry in Korea: Strategies Seth J. Goldenberg, Senior Principal Scientist, NAMSA; Yongha Na, Director, Medipert Regulatory NAMSA Whitepaper #09 06/2014 Seth J. Goldenberg, PhD (sgoldenberg@namsa.com)
More informationRegulatory Considerations for Medical Device Software. Medical Device Software
Medtec Ireland 2015 Wireless Medical Devices Regulatory Considerations for Medical Device Software Kenneth L. Block, RAC October 7, 2015 Galway, Ireland Offices: Dallas, Texas (12 employees) Tokyo, Japan
More informationWhat is a medical device? Medical Devices: Roadmap to Market. Kathryn Klaus, Esq.
Medical Devices: Roadmap to Market Kathryn Klaus, Esq. The last installment of Regulatory 360 discussed the FDA organization in general where it came from and a broad overview of how it operates, as well
More information2. Contact Person: Garo Mimaryan, MS., RAC 7 Technical Regulatory Affairs Specialist III 3. Phone Number: (914)-524-3270
SIEM EN S Abbreviated 510(k) Premnarket Notification IMMULITE 2000 PSA Calibration Verification Material 6. 510(k) Summary as Required by 21 CFR 807.92 K( - is-1 3 (v A. 5 10(k) Number: B. Purpose for
More informationInformation Sheet Guidance For IRBs, Clinical Investigators, and Sponsors
Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors Frequently Asked Questions About Medical Devices Additional copies are available from: Office of Good Clinical Practice Office
More informationDeveloping a Mobile Medical App? How to determine if it is a medical device and get it cleared by the US FDA
Developing a Mobile Medical App? How to determine if it is a medical device and get it cleared by the US FDA In this presentation: App stats: Explosive growth Examples already cleared by the US FDA Is
More informationClinical evaluation Latest development in expectations EU and USA
Clinical evaluation Latest development in expectations EU and USA Medical Devices: staying ahead of regulatory developments Gert Bos BSI Israel 22 April - Herzliya Copyright 2012 BSI. All rights reserved.
More informationMedical Product Development Certificate Program
Life Sciences Medical Product Development Certificate Program Accelerate Your Career extension.uci.edu/mpd In today s competitive business environment, leaders are appointed based on credentials and experience.
More informationPreapproval Inspections for Manufacturing. Christy Foreman Deputy Director Division of Enforcement B Office of Compliance/CDRH
Preapproval Inspections for Manufacturing Christy Foreman Deputy Director Division of Enforcement B Office of Compliance/CDRH Major Steps Review of the Quality System information Inspection requests generated
More informationClinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry
Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry By http://www.clinicalresearchassociate cra.com/studyguide/ A clinical research associate (CRA) is a
More informationGuidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff
Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not
More informationMedical Device Regulatory Requirements for Taiwan
Medical Device Regulatory Requirements for Taiwan Disclaimer: The information contained on this website is derived from public sources and is current to the best of the knowledge of the Department of Commerce
More informationThe Board reviews risks to the Company s business plan at its scheduled meetings.
Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board
More informationJuly 24, 2015. Dear Ms. Rhodes:
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 InnoVision, Incorporated
More informationCorrective and Preventive Action Background & Examples Presented by:
Corrective and Preventive Action Background & Examples Presented by: Kimberly Lewandowski-Walker Food and Drug Administration Division of Domestic Field Investigations Office of Regulatory Affairs Overview
More information21st Century Cures Act: Key Provisions Related to Medical Devices
21st Century Cures Act: Key Provisions Related to Medical Devices July 30, 2015 Food & Drug The 21st Century Cures Act ( the Act or HR 6 ) was passed by the House of Representatives on July 10, 2015, by
More informationORACLE CONSULTING GROUP
ORACLE CONSULTING GROUP 9 Golder Ranch Rd., Ste. 1 Tucson, Arizona 9 Web Site: E-mail: 20-2-0 20-2-0 (FAX) CONSULTING MEMORANDUM QUALITY SYSTEM INSPECTION TECHNIQUE
More informationPerspectives on the FDASIA Health IT Report and Public Workshop
Perspectives on the FDASIA Health IT Report and Public Workshop By Ben Berg, Meaghan Bailey, RAC, and Deborah Baker-Janis On 7 April 2014, a Food and Drug Administration Safety and Innovation Act (FDASIA)-
More informationSharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com Education: Masters of Science, Healthcare Administration, Capital City University,
More informationBIOTECHNOLOGY OPERATIONS
BIOTECHNOLOGY OPERATIONS Principles and Practices Michael J. Roy TECHNISCHE INFORMATION SBIBLIOTHEK UNIVERSITATSBIBLIOTHEK HANNOVER CRC Press TaylorStFrancis Croup Boca Raton London New York CRC Press
More informationMedical Devices. Notified Bodies and the CE certification Process for Medical Devices. European Surgical Robotics Demonstration Day
Medical Devices Notified Bodies and the CE certification Process for Medical Devices European Surgical Robotics Demonstration Day 27 th March 2014, Leuven, Belgium 1 Bart Mersseman Product Manager Medical
More informationGlobal experts in Remediation, Auditing, GMP Compliance, Education and Regulatory Affairs for the Pharma and Biotech Industry
Global experts in Remediation, Auditing, GMP Compliance, Education and Regulatory Affairs for the Pharma and Biotech Industry www.nsf.org The right people. The right solution. The first time. Quality Systems
More informationAC 2007-668: UNDERSTANDING THE MEDICAL PRODUCT DEVELOPMENT PROCESS: CONTINUING PROFESSIONAL DEVELOPMENT FOR LIFE SCIENCE PROFESSIONALS
AC 2007-668: UNDERSTANDING THE MEDICAL PRODUCT DEVELOPMENT PROCESS: CONTINUING PROFESSIONAL DEVELOPMENT FOR LIFE SCIENCE PROFESSIONALS Rogelio Rodriguez, UC Irvine Rogelio C. Rodriguez, M.S. Director,
More informationCOMPLIANCE Solutions. Risky Business? Haunting Prose. 2012 In The Line Of Fire. Responsible Executive MEDICAL DEVICE BUTLER SNOW.
MEDICAL DEVICE COMPLIANCE Solutions Spring, 2012 BUTLER SNOW Haunting Prose Ghostwriting and Transparency in Pharmaceutical and Medical Device Publications Risky Business? Assessing Risks with A Risk Assessment
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 7 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations
More informationWhat Does Having a FDA Cleared Pregnancy Test Mean?
What Does Having a FDA Cleared Pregnancy Test Mean? Clinical Trials Transformation Initiative (CTTI) July 15-16, 2013 Denise N. Johnson-Lyles, Ph.D. Toxicology Branch Chief Division of Chemistry and Toxicology
More informationGuidance for Industry
Guidance for Industry Formal Dispute Resolution: Scientific and Technical Issues Related to Pharmaceutical CGMP U.S. Department of Health and Human Services Food and Drug Administration Center for Drug
More informationMedical Device Software: Establishing FDA Authority and Mobile Medical Apps
Medical Device Software: Establishing FDA Authority and Mobile Medical Apps Seth A. Mailhot, Partner Lead, FDA Regulatory Practice Overview Applying the Definition of a Device to Software Special Categories
More informationAddressing Risk in Partner / Contractor Selection and Onboarding. Michael Davidson VP Quality Systems and Compliance March 2014
Addressing Risk in Partner / Contractor Selection and Onboarding Michael Davidson VP Quality Systems and Compliance March 2014 Industry Trends Pfizer Overview Pfizer s Approach Risk Based Robust Due Diligence
More informationFDA Regulation of Whole Slide Imaging (WSI) Devices: Current Thoughts
FDA Regulation of Whole Slide Imaging (WSI) Devices: Current Thoughts Clinical Laboratory Improvement Advisory Committee Meeting Centers for Disease Control and Prevention February 15, 2012 Tremel A. Faison,
More informationD I Z1. 510(k) Summary. Section 5. Siemens Medical Solutions USA, Inc. Oncology Care Systems. Date Prepared: September 09, 201 0.
Section 5 D I Z1 510(k) Summary Date Prepared: September 09, 201 0 Submitter: Contact: Siemens Medical Solutions USA, Inc. 4040 Nelson Avenue Concord, CA 94520 Christine Dunbar Senior Regulatory Affairs
More informationMay 7, 2015. Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 May 7, 2015 Tactile Systems Technology Inc Daniel
More informationDICOM Grid, Inc. January 25, 2016. Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 DICOM Grid, Inc. Senior
More informationwww.nsf.org The right people. The right solution. The first time.
www.nsf.org The right people. The right solution. The first time. Educational Program Europe January December 2015 Why train with us? The right people. The right solution. The first time. 2 Flexible, Professional
More informationMedical Device Training Program 2015
Medical Device Training Introduction Supplementary training and education is often overlooked by medical device professionals until it is triggered by an upcoming FDA or Notified Body and/or ISO 13485
More informationDeliverable 6: Final Implementation Evaluation Report
Phase 2 Contract Number: HHSF223201010017B, Order No. 22313004 Deliverable 6: Final Implementation Evaluation Report February 1, 2016 TABLE OF CONTENTS 1. EXECUTIVE SUMMARY... 1 2. PROJECT BACKGROUND AND
More information0 EC2 92011 V-,) 133 Lj9a
0 EC2 92011 V-,) 133 Lj9a Section 5: 5 1 0(k) Summar 5 10(K) SUMMARY FOR SOMATOM DEFINITION Flash (with Stellar Detector) Submitted by: Siemens Medical Solutions USA, Inc. 51 Valley Stream Parkway Malvern,
More informationGuidance for Industry and FDA Staff FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND Frequently Asked Questions
Guidance for Industry and FDA Staff FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND Frequently Asked Questions U.S. Department of Health and Human Services Food and Drug Administration
More informationGreat Expectations: Enhanced Obligations in Recent HHS-OIG Corporate Integrity Agreements
Thomas W. Beimers Special Counsel Faegre Baker Daniels LLP Minneapolis MN Great Expectations: Enhanced Obligations in Recent HHS-OIG Corporate Integrity Agreements The Department of Health & Human Services,
More informationRegulation and Risk Management of Combination Products
Regulation and Risk Management of Combination Products Katherine Ulman Associate Scientist Global Regulatory Compliance Manager Dow Corning Healthcare Jim Curtis Senior Specialist, Healthcare Applications
More informationQuality System: Design Control Procedure - Appendix
Quality System: Design Control Procedure - Appendix Page 1 of 10 Quality System: Design Control Procedure - Appendix CORP Medical Products Various details have been removed, indicated by [ ] 1. Overview
More informationDesign Controls: Are They Worth the Effort?
Design Controls: Are They Worth the Effort? Compliance-Alliance conducted a survey to measure the effects of FDA s design control regulation on the industry. Most respondents believe the controls have
More informationDiagnostic Tests. Brad Spring Director, Regulatory Affairs
Regulatory Challenges in the Development of Diagnostic Tests Industry Perspective Brad Spring Director, Regulatory Affairs September 28, 2011 Balancing Evidence of Safety & Effectiveness and Time to Market
More informationOptimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting
More informationAugust 18, 2015. Re: Section 1201 Rulemaking Proposed Exemption for Medical Devices
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 August 18, 2015 Ms. Jacqueline C. Charlesworth General Counsel
More informationNDA 202439/S-008 SUPPLEMENT APPROVAL
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 NDA 202439/S-008 SUPPLEMENT APPROVAL Janssen Pharmaceuticals, Inc. ATTENTION: Alla Rhoge Pharm.D., Associate
More informationEmpowering the Quality and Regulatory Compliance Functions
Empowering the Quality and Regulatory Compliance Functions Management must take steps to ensure that regulatory and quality compliance is everyone s responsibility. By: J. Glenn George, Kenneth Imler,
More informationJUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation
KC6, IL(6/ SPECIAL 510(k) Notification EkoSonic TM Endovascular System JUN 2 6 butt Section 4. General Provisions 510(k) Summary Submitter's Name and Address: Contact Person: Classification Name: EKOS
More informationPMAs, 510(k)s, and Advanced IDE Topics
PMAs, 510(k)s, and Advanced IDE Topics Kenneth J. Cavanaugh Jr., Ph.D. Scientific Reviewer Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health kenneth.cavanaugh@fda.hhs.gov
More informationMedical Billing and Agency Formal Disputes
Guidance for Industry Formal Dispute Resolution: Appeals Above the Division Level Additional copies of this Guidance are available from: Office of Training and Communications Division of Communications
More informationCombination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
More informationLater-Stage Development: Ensuring Compliance During. for a Competitive Advantage Webinar Series
Part II: Later-Stage Development: Ensuring Compliance During Clinical i l Trials Process Driven Compliance for a Competitive Advantage Webinar Series 29 September 2010 Process Driven Compliance Webinar
More informationMobile Medical Applications: An Overview of FDA Regulation
Mobile Medical Applications: An Overview of FDA Regulation RAPS Annual Convention 2014 Austin, Texas Michael A. Swit, Esq. Special Counsel, FDA Law Practice Duane Morris LLP Standard Disclaimers The views
More informationCTC Technology Readiness Levels
CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.
More informationOctober 28, 2015. Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 October 28, 2015 Cavex
More informationDavid M. Stern, M.D. JAN 2 9 7007 Dean, University of Cincinnati College of Medicine 231 Albert Sabin Way Cincinnati, OH 45267
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Serv ice Food and Drug Administration 9200 Corporate Boulevard Rockville, Ma ry land 20850 WARNING LETTER VIA FEDERAL EXPRESS David M. Stern, M.D. JAN
More informationkok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR 807.92(c)) OCT 2 7 2008 1. Applicant
kok1 UQ 510(k) Summary (per 21 CFR 807.92(c)) OCT 2 7 2008 1. Applicant Tech Avenue Ventures d/b/a MPowRx Health and Wellness Products Inc. #510 3553-31 St. NW Calgary, Alberta T2L 2K7 Canada Contact Person:
More informationLife (or is it really?) Under a Consent Decree
Life (or is it really?) Under a Consent Decree Steven Niedelman Lead Quality Systems & Compliance Consultant King & Spalding LLP 1700 Pennsylvania Ave., NW Washington, DC 2006 202-626-2942 sniedelman@kslaw.com
More informationGLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com
GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process
More informationMay 5, 2015. Dear Mr. Courtney:
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 May 5, 2015 Terumo Cardiovascular
More informationALERT. FDA Guidance for Industry and FDA Staff: Mobile Medical Applications. Health & FDA Business November 2013
ALERT Health & FDA Business November 2013 FDA Guidance for Industry and FDA Staff: Mobile Medical Applications On September 25, 2013, the Food and Drug Administration (the FDA ) released final guidance
More informationResults of Technical Network Vulnerability Assessment: EPA s Region 1
U.S. ENVIRONMENTAL PROTECTION AGENCY OFFICE OF INSPECTOR GENERAL Results of Technical Network Vulnerability Assessment: EPA s Region 1 Report No. 12-P-0518 June 5, 2012 Scan this mobile code to learn more
More informationHarmonizing Change Control Processes Globally
Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses
More informationLIBRARY GUIDE: Clinical Medical Device
LIBRARY GUIDE: Clinical Medical Device Table of Contents Overview... 3 Clinical Curriculum Core Program Course Descriptions: A Tour of Health Canada (PHDV89)...5 A Tour of Health Europe (PHDV90)...5 A
More informationLIFESTREAM BEHAVIORAL CENTER, INC. JOINT NOTICE OF PRIVACY PRACTICES. Effective Date: April 14, 2003
LIFESTREAM BEHAVIORAL CENTER, INC. JOINT NOTICE OF PRIVACY PRACTICES Effective Date: April 14, 2003 THIS DOCUMENT DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET
More informationFrancesca M. Pepoon PROFESSIONAL EXPERIENCE AS MANAGING PARTNER OF CONSTRUCTION SCIENCE, MS. PEPOON PROVIDES
SUMMARY OF QUALIFICATIONS MS. PEPOON IS AN ARTICULATE, ENERGETIC AND INNOVATIVE PROJECT MANAGEMENT AND OPERATIONS EXPERT WITH A BROAD RANGE OF EXPERIENCE IN THE CONSTRUCTION, INSURANCE AND BANKING INDUSTRIES.
More informationRoles & Responsibilities of the Sponsor
Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from
More informationOur Team. Your strategic partner for the entire medical product lifecycle. Quality Expertise Efficiency Teamwork
Our Team Your strategic partner for the entire medical product lifecycle At Boston Biomedical Associates, our experienced and dedicated employees define how we work and give us a competitive advantage
More informationGLENDA M. GUEST, BS, CCRA, RQAP-GCP gmg@ncra.com 607-334-5850. Norwich Clinical Research Associates Ltd.
GLENDA M. GUEST, BS, CCRA, RQAP-GCP gmg@ncra.com 607-334-5850 WORK EXPERIENCE Norwich Clinical Research Associates Ltd. Vice-President Vice-Chair of the Board of Directors Director of Marketing 1998 present
More informationDirector IPR Policy and Programs U.S. Customs and Border Protection
Therese Randazzo Director IPR Policy and Programs Therese Randazzo is the Director, IPR Policy and Programs with U.S. Customs and Border Protection (CBP). Ms. Randazzo directs CBP policies and program
More informationJUL 2 2008. Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular Cardiac Therapies 3200 Lakeside Drive Santa Clara, CA 95054-2807
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service JUL 2 2008 Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Kendra Basler Regulatory Affairs Associate Abbott Vascular
More informationGuidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
More informationDOJ Guidance on Use of the False Claims Act in Health Care Matters
DOJ Guidance on Use of the False Claims Act in Health Care Matters The following document is a public document published by the Department of Justice at www.usdoj.gov/dag/readingroom/chcm.htm. U.S. DEPARTMENT
More informationGuidance for Clinical Investigators, Sponsors, and IRBs
Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs Improving Human Subject Protection U.S. Department of Health and Human Services Office of the Commissioner (OC) Center
More informationCurriculum Vitae for Walt Brittle, MBA
Curriculum Vitae for Walt Brittle, MBA Summary of Achievements RABQSA certified Quality Management System Principle Auditor, Scope ISO 13485:2003 certification No. 114542 Expires Dec 2014. Thirty-five
More informationGuidance for Clinical Investigators, Industry, and FDA Staff Financial Disclosure by Clinical Investigators
Guidance for Clinical Investigators, Industry, and FDA Staff Financial Disclosure by Clinical Investigators U.S. Department of Health and Human Services Food and Drug Administration Office of Good Clinical
More informationLIBRARY GUIDE: Pharmaceutical Sales & Marketing
LIBRARY GUIDE: Pharmaceutical Sales & Marketing Page 2 Pharmaceutical Sales and Marketing Course Library Table of Contents: Courses Listed by Functional Area... 4 Basics of the PhRMA Code (PHSM01)...5
More informationFOOD AND DRUG LAW JOURNAL Analyzing the Laws, Regulations, and Policies Affecting FDA-Regulated Products
FOOD AND DRUG LAW JOURNAL Analyzing the Laws, Regulations, and Policies Affecting FDA-Regulated Products Enforcement Protecting the Public s Health Through the Application Integrity Policy Paula R. Katz
More informationSoftware Development for Medical Devices
Overcoming the Challenges of Compliance, Quality and Cost An MKS White Paper Introduction Software is fast becoming the differentiator for manufacturers of medical devices. The rewards available from software
More informationSarah Chandler A/Head, Regulatory and Scientific Section Medical Devices Bureau sarah.chandler@hc-sc.gc.ca
Software Regulated as a Medical Device Sarah Chandler A/Head, Regulatory and Scientific Section Medical Devices Bureau sarah.chandler@hc-sc.gc.ca Therapeutic Products Directorate Director General S. Sharma
More informationAW Server 510 (k) Summary of Safety and Effectiveness
SEP 2 2008 GE Medical Systems AW Server 510 (k) Summary of Safety and Effectiveness This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR
More information